Literature DB >> 19276614

Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7.

Takashi Yanagida1, Yoshihisa Kitamura, Koichiro Yamane, Kazunori Takahashi, Kazuyuki Takata, Daijiro Yanagisawa, Hiroyuki Yasui, Takashi Taniguchi, Takahiro Taira, Toshio Honda, Hiroyoshi Ariga.   

Abstract

Although a loss-of-function type mutation was identified in familial Parkinson's disease PARK7, the wild-type of DJ-1 is known to act as an oxidative stress sensor in neuronal cells. Recently, we found a DJ-1 modulator UCP0054278 by in silico virtual screening. In this study, we determined the neuroprotective effects of UCP0054278 against focal ischemia-induced neurodegeneration in rats. Hydrogen peroxide-induced cell death and the production of reactive oxygen species were significantly inhibited by UCP0054278 in normal SH-SY5Y cells, but not in DJ-1-knockdown cells. These results suggest that UCP0054278 interacts with endogenous DJ-1 and then exhibits antioxidant and neuroprotective responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276614     DOI: 10.1254/jphs.08323sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  9 in total

Review 1.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

2.  PARIS-DJ-1 Interaction Regulates Mitochondrial Functions in Cardiomyocytes, Which Is Critically Important in Cardiac Hypertrophy.

Authors:  Dibyanti Mukherjee; Vivek Chander; Arun Bandyopadhyay
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

3.  DJ-1/PARK7, But Not Its L166P Mutant Linked to Autosomal Recessive Parkinsonism, Modulates the Transcriptional Activity of the Orphan Nuclear Receptor Nurr1 In Vitro and In Vivo.

Authors:  Lingling Lu; Shasha Zhao; Ge Gao; Xiaohong Sun; Huanying Zhao; Hui Yang
Journal:  Mol Neurobiol       Date:  2016-02-12       Impact factor: 5.590

Review 4.  Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism.

Authors:  Erika Olivo; Marina La Chimia; Jessica Ceramella; Alessia Catalano; Ferdinando Chiaradonna; Maria Stefania Sinicropi; Giovanni Cuda; Domenico Iacopetta; Domenica Scumaci
Journal:  Cells       Date:  2022-04-23       Impact factor: 7.666

5.  Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats.

Authors:  Yoshihisa Kitamura; Shotaro Watanabe; Masanobu Taguchi; Kentaro Takagi; Takuya Kawata; Kazuko Takahashi-Niki; Hiroyuki Yasui; Hiroshi Maita; Sanae Mm Iguchi-Ariga; Hiroyoshi Ariga
Journal:  Mol Neurodegener       Date:  2011-07-08       Impact factor: 14.195

Review 6.  Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.

Authors:  Uma A Mukherjee; Sang-Bing Ong; Sang-Ging Ong; Derek J Hausenloy
Journal:  Pharmacol Ther       Date:  2015-10-19       Impact factor: 12.310

7.  Comparison of plasma PARK7 and NDKA diagnostic value in acute stroke.

Authors:  Dieudonne Steve M Tulantched; Zhao Min; Wang-Xiao Feng
Journal:  Future Sci OA       Date:  2019-02-12

Review 8.  DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives.

Authors:  Mariaelena Repici; Flaviano Giorgini
Journal:  J Clin Med       Date:  2019-09-03       Impact factor: 4.241

Review 9.  PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Ádám Vannay
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.